29,200 Shares in Astera Labs, Inc. $ALAB Bought by Varma Mutual Pension Insurance Co

Varma Mutual Pension Insurance Co bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, HoldingsChannel reports. The fund bought 29,200 shares of the company’s stock, valued at approximately $14,104,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Reflection Asset Management acquired a new position in shares of Astera Labs during the 4th quarter worth about $25,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the second quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs during the fourth quarter worth about $33,000. Finally, Whipplewood Advisors LLC boosted its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Price Performance

ALAB opened at $284.97 on Monday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The business has a 50 day moving average of $352.70 and a 200-day moving average of $245.57. The stock has a market cap of $49.44 billion, a price-to-earnings ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on ALAB. Royal Bank Of Canada raised their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Stifel Nicolaus raised their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, Needham & Company LLC boosted their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the transaction, the director directly owned 4,631 shares of the company’s stock, valued at $2,083,950. This represents a 66.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is currently owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.